Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy
Clinical trial NCT04962126 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04962126
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2023-04-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.